Research Areas

The launch marks a major step toward more predictive, human-relevant drug development using microphysiological systems.

A team from Stanford and NYU shows how Bacteroides fragilis can activate pain pathways, revealing a new microbial culprit in digestive disease.

Vaxart aims to revolutionize immunization by replacing injections with easy-to-take tablets.

Positive results for a radioligand therapy, a billion-dollar deal for a MASH drug, the Nobel Prize for immune system research, and more led the news this week.

The funding round will support expanded US manufacturing and accelerate the company’s enzymatic DNA synthesis technology.

Structural insights reveal how DCAF2 can be harnessed to target previously untouchable proteins for degradation.

Explore the evolution of DNA synthesis, its expanding applications, and the considerations that guide synthesis choices.

Nearly 25 percent of non-antibiotic drugs tested in the study enabled the proliferation of enteropathogens.

Collaboration integrates Agilent’s SureSelect Max DNA Library Prep Kits with SPT Labtech’s firefly+ platform, streamlining genomic sequencing with hands-free automation.

The collaboration combines Celonic’s biologics expertise with Carbogen Amcis’s payload and conjugation capabilities to create a seamless, end-to-end ADC development pathway.